Potent T cell Responses Induced by Single DNA Vaccine Boosted with Recombinant Vaccinia Vaccine

被引:0
作者
Lianxing Liu [1 ,2 ]
Chao Qiu [3 ]
Yang Huang [3 ]
Jianqing Xu [3 ]
Yiming Shao [1 ,2 ]
机构
[1] State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences
[2] State Key Laboratory for Infectious Diseases Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention
[3] Science Research Department, Shanghai Public Health Clinical Center, Public Health Clinical Center affiliated to Fudan University
基金
中国国家自然科学基金;
关键词
HIV; Vaccine; T cell responses; Prime-boost regimen;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Plasmid DNA, an effective vaccine vector, can induce both cellular and humoral immune responses. However, plasmid DNA raises issues concerning potential genomic integration after injection. This issue should be considered in preclinical studies. Tiantan vaccinia virus (TV) has been most widely utilized in eradicating smallpox in China. This virus has also been considered as a successful vaccine vector against a few infectious diseases. Potent T cell responses through T-cell receptor (TCR) could be induced by three injections of the DNA prime vaccine followed by a single injection of recombinant vaccinia vaccine. To develop a safer immunization strategy, a single DNA prime followed by a single recombinant Tiantan vaccinia (rTV) AIDS vaccine was used to immunize mice. Our data demonstrated that one DNA prime/rTV boost regimen induced mature TCR activation with high functional avidity, preferential T cell Vβ receptor usage and high sensitivity to anti-CD3 antibody stimulation. No differences in T cell responses were observed among one, two or three DNA prime/rTV boost regimens. This study shows that one DNA prime/rTV boost regimen is sufficient to induce potent T cell responses against HIV.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 7 条
[1]   人类免疫缺陷病毒DNA疫苗黏膜免疫小鼠免疫力研究 [J].
黄相刚 ;
徐建青 ;
任莉 ;
仇超 ;
张宁 ;
刘连兴 ;
万延民 ;
彭虹 ;
邵一鸣 .
中华医学杂志, 2006, (44) :3109-3113
[2]   HIV-1 B'亚型gag-env融合基因的DNA疫苗构建和免疫原性分析 [J].
任莉 ;
仇超 ;
黄相刚 ;
潘翔 ;
徐建青 ;
邵一鸣 .
中华微生物学和免疫学杂志, 2006, (07) :654-658
[3]  
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial[J] . Susan P Buchbinder,Devan V Mehrotra,Ann Duerr,Daniel W Fitzgerald,Robin Mogg,David Li,Peter B Gilbert,Javier R Lama,Michael Marmor,Carlos del Rio,M Juliana McElrath,Danilo R Casimiro,Keith M Gottesdiener,Jeffrey A Chodakewitz,Lawrence Corey,Michael N Robertson. The Lancet . 2008 (9653)
[4]   Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes [J].
Xu, Jianqing ;
Ren, Li ;
Huang, Xianggang ;
Qiu, Chao ;
Liu, Yong ;
Liu, Ying ;
Shao, Yiming .
AIDS, 2006, 20 (18) :2293-2303
[5]  
DNA vaccines for viral infections: Basic studies and applications[J] . Harriet L Robinson,Tamera M Pertmer. Advances in Virus Research . 2000
[6]  
The prime-boost strategy: exciting prospects for improved vaccination[J] . Ian A Ramshaw,Alistair J Ramsay. Immunology Today . 2000 (4)
[7]  
DNA Vaccines: Technology and Application as Anti-parasite and Anti-microbial Agents[J] . Jason B. Alarcon,Gary W. Waine,Donald P. McManus. Advances in Parasitology . 1999